Torrent Pharmaceuticals Ltd (GREY:TQRRY)
$ 0 0 (0%) Market Cap: - Enterprise Value: 4.56 Bil PE Ratio: 60.09 PB Ratio: 14.43 GF Score: 94/100

Q1 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Jul 27, 2021 / 01:00PM GMT
Operator

Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q1 FY '22 Earnings Conference Call. We have with us today Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Executive Director and Chief Financial Officer; and Aman Mehta, Chief Marketing Officer, India business. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you, and hi, good evening, everyone, and welcome to Torrent 1 -- Torrent quarter 1 FY '22 earnings call. At the outset, quarter 1 growth was backed by continued growth momentum in the branded generic market, mainly India and Brazil. The second wave of pandemic impacted the recovery trends across some of the key markets we operate.

Very shortly, in terms of financial performance during the quarter, revenues were INR 2,134 crores, up by 4% on a year-on-year basis. EBITDA was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot